Log in
NYSE:CSLT

Castlight Health Stock Forecast, Price & News

$1.06
-0.03 (-2.75 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.06
Now: $1.06
$1.11
50-Day Range
$1.06
MA: $1.19
$1.38
52-Week Range
$0.60
Now: $1.06
$1.79
Volume132,524 shs
Average Volume888,008 shs
Market Capitalization$159.67 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services. It serves customers in a range of industries, including education, manufacturing, retail, technology, and government. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was founded in 2008 and is headquartered in San Francisco, California.
Read More
Castlight Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.8Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars


Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
CUSIPN/A
Phone415-829-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$143.31 million
Book Value$1.17 per share

Profitability

Net Income$-40,000,000.00

Miscellaneous

Employees470
Market Cap$159.67 million
Next Earnings Date10/22/2020 (Estimated)
OptionableOptionable
$1.06
-0.03 (-2.75 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CSLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Castlight Health (NYSE:CSLT) Frequently Asked Questions

How has Castlight Health's stock been impacted by Coronavirus?

Castlight Health's stock was trading at $0.83 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSLT stock has increased by 27.7% and is now trading at $1.06.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Castlight Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Castlight Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Castlight Health
.

When is Castlight Health's next earnings date?

Castlight Health is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Castlight Health
.

How were Castlight Health's earnings last quarter?

Castlight Health Inc (NYSE:CSLT) issued its quarterly earnings results on Tuesday, July, 28th. The software maker reported ($0.01) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.06. The software maker had revenue of $35.50 million for the quarter, compared to analysts' expectations of $30.40 million. Castlight Health had a negative net margin of 55.73% and a negative return on equity of 16.36%.
View Castlight Health's earnings history
.

What guidance has Castlight Health issued on next quarter's earnings?

Castlight Health issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, July, 28th. The company provided earnings per share (EPS) guidance of -0.16--0.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.13. The company issued revenue guidance of $127-135 million, compared to the consensus revenue estimate of $130.78 million.

What price target have analysts set for CSLT?

3 Wall Street analysts have issued 1 year price objectives for Castlight Health's stock. Their forecasts range from $0.75 to $2.00. On average, they expect Castlight Health's stock price to reach $1.25 in the next year. This suggests a possible upside of 17.9% from the stock's current price.
View analysts' price targets for Castlight Health
.

Who are some of Castlight Health's key competitors?

What other stocks do shareholders of Castlight Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Castlight Health investors own include Zosano Pharma (ZSAN), Matinas BioPharma (MTNB), BioNano Genomics (BNGO), ADMA Biologics (ADMA), Chesapeake Energy (CHKAQ), OrganiGram (OGI), AEterna Zentaris (AEZS), Hallador Energy (HNRG), Miragen Therapeutics (MGEN) and Novan (NOVN).

Who are Castlight Health's key executives?

Castlight Health's management team includes the following people:
  • Dr. Bryan Eisman Roberts, Chairman (Age 52)
  • Mr. John C. Doyle, CEO & Director (Age 51)
  • Ms. Siobhan Nolan Mangini, Chief Financial Officer (Age 38)
  • Mr. M P Eric Chan, Chief Accounting Officer (Age 43)
  • Mr. Gary J. Fuges C.F.A., CFA, Head of Investor Relations

What is Castlight Health's stock symbol?

Castlight Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CSLT."

Who are Castlight Health's major shareholders?

Castlight Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include FMR LLC (11.40%), Venrock Management V LLC (10.08%), Gagnon Securities LLC (2.80%), Venrock Partners Management V LLC (0.85%), Jane Street Group LLC (0.43%) and Bridgeway Capital Management Inc. (0.40%). Company insiders that own Castlight Health stock include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta, Seth B Cohen, William Bondurant and Zant Kenny Van.
View institutional ownership trends for Castlight Health
.

Which major investors are selling Castlight Health stock?

CSLT stock was sold by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., and Goldman Sachs Group Inc.. Company insiders that have sold Castlight Health company stock in the last year include Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta, Seth B Cohen, and William Bondurant.
View insider buying and selling activity for Castlight Health
.

Which major investors are buying Castlight Health stock?

CSLT stock was bought by a variety of institutional investors in the last quarter, including Venrock Management V LLC, Venrock Partners Management V LLC, Jane Street Group LLC, RBF Capital LLC, Assenagon Asset Management S.A., Bank of America Corp DE, Two Sigma Advisers LP, and Edge Wealth Management LLC. Company insiders that have bought Castlight Health stock in the last two years include Maeve O'meara, William Bondurant, and Zant Kenny Van.
View insider buying and selling activity for Castlight Health
.

How do I buy shares of Castlight Health?

Shares of CSLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Castlight Health's stock price today?

One share of CSLT stock can currently be purchased for approximately $1.06.

How big of a company is Castlight Health?

Castlight Health has a market capitalization of $159.67 million and generates $143.31 million in revenue each year. The software maker earns $-40,000,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Castlight Health employs 470 workers across the globe.

What is Castlight Health's official website?

The official website for Castlight Health is www.castlighthealth.com.

How can I contact Castlight Health?

Castlight Health's mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker can be reached via phone at 415-829-1400 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.